ANADARKO PETROLEUM
CORPORATION
(a Delaware corporation)
Debt Securities
UNDERWRITING AGREEMENT
(Standard Provisions)
To the
Representatives of the several Underwriters named in
the respective Terms Agreements hereinafter described.
Anadarko
Petroleum Corporation, a Delaware corporation (the “
Company ”), proposes to issue and sell its debt
securities (the “ Securities ”) in one or more
offerings on terms determined at the time of sale. The Securities
will be issued in one or more series under an indenture specified
in the applicable Terms Agreement (the “ Indenture
”). Each series of Securities to be issued may vary as to
aggregate principal amount, currency, maturity, interest rate or
rates and timing of payments thereof, redemption provisions,
sinking fund requirements, conversion provisions, if any, and any
other variable terms which the Indenture contemplates may be set
forth in the Securities as issued from time to time.
The
provisions included herein (the “ Standard Provisions
”) shall be incorporated by reference into each Terms
Agreement. The term “you” or “your” as used
herein, unless the context otherwise requires, shall mean such of
the parties to whom these Standard Provisions are addressed as are
named in the applicable Terms Agreement.
Each
offering of Securities will be made through one or more of you or
through an underwriting syndicate managed by one or more of you.
Whenever the Company determines to make an offering of Securities,
it will enter into an agreement substantially in the form of
Exhibit A hereto (the “ Terms Agreement ”)
providing for the sale of such Securities to, and the purchase and
offering thereof by, one or more of you and such other
underwriters, if any, selected by you as have authorized you to
enter into such Terms Agreement on their behalf (the “
Underwriters ,” which term shall include you whether
acting alone in the sale of Securities or as members of an
underwriting syndicate). The representative or representatives of
the Underwriters, if any, specified in a Terms Agreement are
hereinafter referred to as the “ Representatives
.” The Terms Agreement relating to each offering of
Securities shall specify the principal amount of each series of the
Securities to be issued, whether such Securities are senior or
subordinated debt securities, and their terms not otherwise
specified in the Indenture, the names of the Underwriters
participating in such offering (subject to substitution as provided
in Section 9 hereof) and the principal amount of each series
of the Securities which each Underwriter severally agrees to
purchase (collectively, the “ Firm Securities
”), the names of such of you and such other Underwriters, if
any, acting as co-managers in connection with such offering, the
price at which each series of the Securities are to be purchased by
the Underwriters from the Company, the initial public offering
price of each such series and the time and place of delivery and
payment.
In addition,
the Terms Agreement shall specify the maximum principal amount of
each series of the Securities, if any (the “ Additional
Securities ”), that the Company proposes to issue and
sell to the Underwriters if and to the extent that you shall have
determined to exercise, on behalf of the several Underwriters, the
right to purchase such Additional Securities. The Terms Agreement
may take the form of an exchange of any standard form of written
telecommunication between you and the Company. Each offering of
Securities will be governed by these Standard Provisions, as
supplemented by the applicable Terms Agreement, and these Standard
Provisions and such Terms Agreement shall inure to the benefit of
and be binding upon each Underwriter participating in the offering
of such Securities.
All
references in these Standard Provisions to financial statements and
schedules and other information which is “contained,”
“included” or “stated” (or other references
of like import) in the Registration Statement, Disclosure Package,
Prospectus or preliminary prospectus shall be deemed to mean and
include all such financial statements and schedules and other
information which are incorporated by reference in the Registration
Statement, Prospectus or preliminary prospectus, as the case may
be, prior to the execution of the applicable Terms Agreement; and
all references in these Standard Provisions to amendments or
supplements to the Registration Statement, Prospectus, Disclosure
Package or preliminary prospectus shall be deemed to include the
filing (as opposed to furnishing) of any document under the
Exchange Act which is incorporated by reference in the Registration
Statement, Prospectus, Disclosure Package or preliminary
prospectus, as the case may be, after the execution of the
applicable Terms Agreement.
For
purposes of these Standard Provisions:
“ 430B
Information ” means information included in a prospectus
then deemed to be a part of the Registration Statement pursuant to
Rule 430B(e) or retroactively deemed to be a part of the
Registration Statement pursuant to Rule 430B(f).
“ 430C
Information ” means information included in a prospectus
then deemed to be a part of the Registration Statement pursuant to
Rule 430C.
“
Act ” means the Securities Act of 1933, as
amended.
“Applicable Time”
means the time and date so stated in
the Terms Agreement.
“
Closing Date” has the meaning defined in
Section 2 hereof.
“
Commission ” means the Securities and Exchange
Commission.
“
Effective Date ” of the Registration Statement
relating to the Securities means the time of the first contract of
sale for the Securities.
“
Exchange Act ” means the Securities Exchange Act of
1934, as amended.
“General Use Issuer Free Writing
Prospectus” means
any Issuer Free Writing Prospectus that is intended for general
distribution to prospective investors, as evidenced by its being so
specified in a schedule to the Terms Agreement.
2
“Issuer Free Writing
Prospectus” means
any “issuer free writing prospectus,” as defined in
Rule 433, relating to the Securities in the form filed or
required to be filed with the Commission or, if not required to be
filed, in the form retained in the Company’s records pursuant
to Rule 433(g).
“Limited Use Issuer Free Writing
Prospectus” means
any Issuer Free Writing Prospectus that is not a General Use Issuer
Free Writing Prospectus.
“
Prospectus ” means the Statutory Prospectus that
discloses the public offering price, other 430B Information and
other final terms of the Securities and otherwise satisfies Section
10(a) of the Act.
“Registration Statement”
at any particular time means such
registration statement in the form then filed with the Commission,
including any amendment thereto, any document incorporated by
reference therein and all 430B Information and all 430C Information
with respect to such registration statement, that in any case has
not been superseded or modified. “ Registration
Statement ” without reference to a time means the
Registration Statement as of the Effective Date. For purposes of
this definition, 430B Information shall be considered to be
included in the Registration Statement as of the time specified in
Rule 430B.
“
Rules and Regulations ” means the rules and
regulations of the Commission.
“Statutory Prospectus”
with reference to any particular
time means the prospectus relating to the Securities that is
included in the Registration Statement immediately prior to that
time, including all 430B Information and all 430C Information with
respect to the Registration Statement. For purposes of the
foregoing definition, 430B Information shall be considered to be
included in the Statutory Prospectus only as of the actual time
that form of prospectus (including a prospectus supplement) is
filed with the Commission pursuant to Rule 424(b) and not
retroactively.
“Terms
Agreement” means
the Terms Agreement referred to in Section 2 relating to the
Securities.
“Trust
Indenture Act ”
means the Trust Indenture Act of 1939, as amended.
Unless
otherwise specified, a reference to a “ rule ”
is to the indicated rule under the Act.
Section 1.
Representations and Warranties. The Company represents and
warrants to each of you, and to each Underwriter named in a Terms
Agreement as of the date thereof as follows:
(a) The
Company has filed with the Commission a registration statement on
Form S-3 (No. 333-137183), including a related prospectus or
prospectuses, covering the registration of the Securities under the
Act, which has become effective.
(b) The
Registration Statement constitutes an “ automatic shelf
registration statement ” (as defined in Rule 405 of
the Act) filed within three years of the date of the applicable
Terms
3
Agreement, and
the Company is a “ well-known seasoned issuer ”
(as defined in Rule 405 of the Act). The Company has not
received from the Commission any notice pursuant to
Rule 401(g)(2) objecting to use of the automatic shelf
registration statement form. If at any time when any Securities
remain unsold by the Underwriters the Company receives from the
Commission a notice pursuant to Rule 401(g)(2) or otherwise
ceases to be eligible to use the automatic shelf registration
statement form, the Company will (i) promptly notify the
Representatives, (ii) promptly file a new registration statement or
post-effective amendment on the proper form relating to the
Securities, in a form reasonably satisfactory to the
Representatives, (iii) use its reasonable best efforts to
cause such registration statement or post-effective amendment to be
declared effective as soon as practicable, and (iv) promptly
notify the Representatives of such effectiveness. The Company will
take all other action reasonably necessary or appropriate to permit
the public offering and sale of the Securities to continue as
contemplated in the registration statement that was the subject of
the Rule 401(g)(2) notice or for which the Company has
otherwise become ineligible. References herein to the Registration
Statement shall include such new registration statement or
post-effective amendment, as the case may be. The Company has paid
or shall pay the required Commission filing fees relating to the
Securities within the time required by Rule 456(b)(1) without
regard to the proviso therein and otherwise in accordance with
Rules 456(b) and 457(r).
(c) (i) At
the time of filing the Registration and (ii) at the date of
the Terms Agreement, the
Company was not and is not an “ineligible issuer,” as
defined in Rule 405.
(d) (i)
(A) At the time the Registration Statement initially became
effective, (B) at the time of each amendment thereto for the
purposes of complying with Section 10(a)(3) of the Act
(whether by post-effective amendment, incorporated report or form
of prospectus), (C) on the Effective Date relating to the
Securities and (D) on the Closing Date, the Registration
Statement conformed and will conform in all material respects to
the requirements of the Act, the Trust Indenture Act and the Rules
and Regulations and did not and will not include any untrue
statement of a material fact or omit to state any material fact
required to be stated therein or necessary to make the statements
therein not misleading and (ii) (A) on its date, (B) at
the time of filing the Prospectus pursuant to Rule 424(b) and
(C) on the Closing Date, the Prospectus will conform in all
material respects to the requirements of the Act, the Trust
Indenture Act and the Rules and Regulations, and will not include
any untrue statement of a material fact or omit to state any
material fact necessary in order to make the statements therein, in
the light of the circumstances under which they were made, not
misleading. The preceding sentence does not apply to (i) statements
in or omissions from any such document made in reliance upon and in
conformity with written information furnished to the Company by any
Underwriter through the Representatives, if any, specifically for
use therein, it being understood and agreed that the only such
information is that described as such in the Terms Agreement or
(ii) that part of the Registration Statement that will
constitute the Statement of Eligibility and Qualification under the
Trust Indenture Act (Form T-1) of the Trustee under the Indenture
(the “ Form T-1 ”).
(e) As of the
Applicable Time, neither (i) the General Use Issuer Free
Writing Prospectus(es) issued at or prior to the Applicable Time,
the Statutory Prospectus identified in a schedule to the Terms
Agreement, and any other documents listed or disclosures stated in
a schedule to the Terms Agreement to be included in the Disclosure
Package, all considered together (collectively, the
“Disclosure Package” ), nor (ii) any
individual Limited Use Issuer Free Writing Prospectus, when
considered together with the Disclosure Package, included
any
4
untrue
statement of a material fact or omitted to state any material fact
necessary in order to make the statements therein, in the light of
the circumstances under which they were made, not misleading. The
preceding sentences do not apply to statements in or omissions from
any Statutory Prospectus or any Issuer Free Writing Prospectus in
reliance upon and in conformity with written information furnished
to the Company by any Underwriter through the Representatives
specifically for use therein, it being understood and agreed that
the only such information is that described as such in the Terms
Agreement.
(f) Each
Issuer Free Writing Prospectus, as of its issue date and at all
subsequent times through the completion of the public offer and
sale of the Securities or until any earlier date that the Company
notified or notifies the Representatives as described in the next
sentence, did not, does not and will not include any information
that conflicted, conflicts or will conflict with the information
then contained in the Registration Statement. If at any time
following issuance of an Issuer Free Writing Prospectus there
occurred or occurs an event or development as a result of which
such Issuer Free Writing Prospectus conflicted or would conflict
with the information then contained in the Registration Statement
or as a result of which such Issuer Free Writing Prospectus, if
republished immediately following such event or development, would
include an untrue statement of a material fact or omitted or would
omit to state a material fact necessary in order to make the
statements therein, in the light of the circumstances prevailing at
that subsequent time, not misleading, (i) the Company has
promptly notified or will promptly notify the Representatives and
(ii) the Company has promptly amended or will promptly amend
or supplement such Issuer Free Writing Prospectus to eliminate or
correct such conflict, untrue statement or omission. The preceding
sentences do not apply to statements in or omissions from any
Issuer Free Writing Prospectus in reliance upon and in conformity
with written information furnished to the Company by any
Underwriter through the Representatives specifically for use
therein, it being understood and agreed that the only such
information is that described as such in the Terms
Agreement.
(g) The
accountants who certified the financial statements of each of the
Company, Kerr-McGee Corporation, a Delaware corporation wholly
owned by the Company (“ KMG ”), and Western Gas
Resources, Inc., a Delaware corporation wholly owned by the Company
(“ Western ”), included or incorporated in the
Registration Statement, the Prospectus and the Disclosure Package
are independent public accountants as required by the Act and the
rules and regulations thereunder.
(h) The
consolidated financial statements of each of the Company, KMG and
Western, together with related schedules and notes, included or
incorporated in the Registration Statement, the Prospectus and the
Disclosure Package present fairly the consolidated financial
position of each such corporation and its subsidiaries as of the
dates indicated and the results of their operations and the changes
in their financial position for the periods specified; said
financial statements have been prepared in conformity with
generally accepted accounting principles consistently applied
during the period, except as stated therein.
If
applicable, the pro forma financial information set forth or
incorporated by reference in the Registration Statement, the
Prospectus and the Disclosure Package is, in all material respects,
fairly presented and prepared on a basis consistent with the
historical financial statements of the
5
Company and its
subsidiaries, except to the extent stated therein, and gives effect
to assumptions used in the preparation thereof which have been made
on a reasonable basis and in good faith.
(i) The
Company has established and maintains disclosure controls and
procedures (as such term in defined in Rule 13a-15 under the
Exchange Act); such disclosure controls and procedures are designed
to ensure that material information relating to the Company and its
subsidiaries is made known to the chief executive officer and chief
financial officer of the Company by others within the Company or
any subsidiary, and such disclosure controls and procedures are
reasonably effective to perform the functions for which they were
established subject to the limitations of any such control system.
The Company and each of its subsidiaries maintain a system of
internal accounting controls sufficient to provide reasonable
assurances that (A) transactions are executed in accordance
with management’s general or specific authorization;
(B) transactions are recorded as necessary to permit
preparation of financial statements in conformity with generally
accepted accounting principles and to maintain accountability for
assets; (C) access to assets is permitted only in accordance
with management’s general or specific authorization; and
(D) the recorded accountability for assets is compared with
the existing assets at reasonable intervals and appropriate action
is taken with respect to any differences. The Company’s
auditors and the audit committee of the board of directors of the
Company have been advised of: (A) any significant deficiencies
in the design or operation of internal controls which could
adversely affect the Company’s ability to record, process,
summarize, and report financial data; and (B) any fraud,
whether or not material, that involves management or other
employees who have a role in the Company’s internal controls;
any material weaknesses in internal controls have been identified
for the Company’s auditors; and since the date of the most
recent evaluation of such disclosure controls and procedures, there
have been no significant changes in internal controls or in other
factors that could significantly affect internal controls,
including any corrective actions with regard to significant
deficiencies and material weaknesses. The Company made available to
the Underwriters or their counsel for review true and complete
copies of all minutes or draft minutes of meetings, or resolutions
adopted by written consent, of the board of directors of the
Company and each subsidiary and each committee of each such board
in the past three years, and all agendas for each such meeting for
which minutes or draft minutes do not exist.
(j) Except as
described in the Disclosure Package as of the Applicable Time,
since the date of the latest audited financial statements included
or incorporated by reference in the Disclosure Package, there has
been no change, nor any development or event involving a
prospective change, in the financial condition, results of
operations, business, properties or prospects of the Company and
its subsidiaries, taken as a whole, that is material and adverse (a
“ Material Adverse Change ”).
(k) Except as
described in the Disclosure Package as of the Applicable Time,
since the date of the latest audited financial statements included
or incorporated by reference in the Disclosure Package, no
litigation or governmental proceeding has been instituted or, to
the knowledge of the Company, threatened against the Company or any
subsidiary which would reasonably be expected to have any material
adverse effect on the financial condition, results of operations,
business, properties or prospects of the Company and its
subsidiaries taken as a whole (a “ Material Adverse
Effect ”).
6
(l) The
Company has been duly incorporated and is validly existing as a
corporation in good standing under the laws of the State of
Delaware with the corporate power and authority to own, lease and
operate its properties and conduct its business as described in the
Prospectus and the Disclosure Package; and the Company is duly
qualified or licensed to do business as a foreign corporation in
good standing in each jurisdiction in which the conduct of its
business or its ownership or leasing of property requires such
qualification or licensing, except to the extent that the failure
to be so qualified or licensed or be in good standing would not
have a Material Adverse Effect.
(m) Each
significant subsidiary of the Company within the meaning of
Regulation S-X (each “ Significant Subsidiary
”) is a duly incorporated or formed and validly existing
corporation, partnership or limited liability company, as
applicable, in good standing under the laws of its jurisdiction of
incorporation or formation with full corporate, partnership or
limited liability company power and authority to own, lease and
operate its properties and conduct its business as described in the
Prospectus and the Disclosure Package. Each Significant Subsidiary
is duly qualified or licensed to do business as a foreign
corporation, partnership or limited liability company in good
standing in each jurisdiction in which the conduct of its business
or its ownership or leasing of property requires such qualification
or licensing, except to the extent that the failure to be so
qualified or licensed or be in good standing would not have a
Material Adverse Effect. The issued and outstanding common stock or
other equity interests of each of the Significant Subsidiaries have
been duly authorized and validly issued and are fully paid and
non-assessable and, except as disclosed in the Prospectus and the
Disclosure Package, are owned by the Company free and clear of any
mortgages, liens or similar encumbrances.
(n) Neither
the Company nor any Significant Subsidiary is in violation of its
certificate of incorporation or bylaws or similar organizational
documents, and neither the Company nor any Significant Subsidiary
is in default in the performance or observance of any obligation in
any indenture, mortgage, evidence of indebtedness or similar
agreement or instrument to which it is a party or by which it or
any of its properties may be bound which default would have a
Material Adverse Effect. The execution and delivery of the
applicable Terms Agreement, incorporating these Standard
Provisions, and the consummation of the transactions contemplated
herein and therein and the incurrence of the obligations herein and
therein set forth, have been or will be duly authorized by all
necessary corporate action and do not and will not, conflict with,
or constitute or result in a breach of or default under, the
certificate of incorporation or bylaws of the Company or, except
for any such conflict, breach or default which would not have a
Material Adverse Effect, any law, order, rule, regulation or court
decree or any bond, debenture, note or other evidence of
indebtedness or any material contract, lease, license, indenture,
mortgage, loan agreement or other agreement or instrument to which
the Company or any of its subsidiaries is a party or by which the
Company or any of its subsidiaries or any of their respective
properties may be bound; and the Company has full corporate power
and authority to issue and sell the Securities as contemplated by
the applicable Terms Agreement, including these Standard
Provisions.
(o) No
consent, approval, authorization, order or qualification or
registration of or with any court or governmental agency or body is
required for the consummation of the transactions contemplated
herein, except for (i) the registration of the offer and sale
of the Securities under the Act and such consents, approvals,
authorizations, orders, qualifications or registrations
as
7
may be required
under the Blue Sky or securities laws of any jurisdiction in
connection with the purchase and distribution of the Securities by
the Underwriters; (ii) the qualification of the Indenture
under the Trust Indenture Act; and (iii) such consents,
approvals, authorizations, orders, qualifications or registrations,
the failure of which to obtain or make would not individually or in
the aggregate, have a Material Adverse Effect.
(p) The
Company and each Significant Subsidiary possess such valid
franchises, certificates of convenience and necessity, easements,
rights of way, operating rights, licenses, permits, consents,
authorizations and orders of governmental political subdivisions or
regulatory authorities as, in the opinion of the Company, are
necessary to carry on the respective businesses of each as
described in the Prospectus and the Disclosure Package, except
where the failure to possess such would not have a Material Adverse
Effect.
(q) Except as
disclosed in the Disclosure Package and except for matters that
would not, individually or in the aggregate, have a Material
Adverse Effect: (i) the Company and its subsidiaries and their
respective properties and operations are and, during the relevant
time periods specified in all applicable statutes of limitations,
have been in compliance with all applicable laws, rules,
regulations, ordinances, codes, orders, and other legally
enforceable requirements relating to the prevention of pollution,
the preservation of environmental quality, the protection of
natural resources, or the remediation of environmental
contamination (collectively, “ Environmental Laws
”); (ii) the Company and its subsidiaries and their
respective properties and operations are not subject to any
proceeding, lawsuit, or other legal action or, to the
Company’s knowledge, any investigation or inquiry, by or
before any governmental authority pursuant to any Environmental
Law; (iii) the Company and its subsidiaries and their
respective properties and operations are not subject to any
liability (including any obligation to perform any investigatory,
corrective or remedial action that has been asserted) pursuant to
Environmental Laws in connection with any release into the
environment of, or any exposure of any person or property to, any
pollutant, contaminant, solid or hazardous waste, hazardous or
toxic substance, or any other material regulated under
Environmental Laws.
(r) Except as
disclosed in the Disclosure Package and the Prospectus, the Company
and its subsidiaries have (i) generally satisfactory title to
their oil and gas properties, title investigations having been
carried out by the Company in accordance with the practice in the
oil and gas industries in the areas in which the Company operates,
(ii) good and marketable title to all other real property
owned by them to the extent necessary to carry on their business
and (iii) good and marketable title to all personal property owned
by them, in each case free from liens, encumbrances and defects
that would materially affect the value thereof or materially
interfere with the use made or to be made thereof by them; and
except as disclosed in the Disclosure Package and the Prospectus,
the Company and its subsidiaries hold any leased real or personal
property under valid and enforceable leases with no exceptions that
would materially interfere with the use made or to be made thereof
by them.
(s) (i) The
oil and natural gas reserve estimates of the Company and its
subsidiaries, including KMG and Western, as of December 31,
2003, 2004 and 2005 contained in the Disclosure Package and the
Prospectus are derived from (a) reports that have been
prepared by Netherland, Sewell & Associates, Inc., or
(b) reports prepared by the Company and examined by
Netherland, Sewell & Associates, Inc., as set forth and to the
extent indicated therein, and
8
(ii) such
estimates reasonably reflect the oil and natural gas reserves of
the Company and its subsidiaries, as applicable, at the dates
indicated therein and are in accordance, in all material respects,
with Commission guidelines applied on a consistent basis throughout
the periods involved.
(t) Netherland,
Sewell & Associates, Inc. have represented to the Company that
they are, and the Company believes them to be, independent
petroleum engineers with respect to the Company and its
subsidiaries and for the periods set forth in the Disclosure
Package and the Prospectus.
(u) The
applicable Terms Agreement, incorporating these Standard
Provisions, has been duly authorized, executed and delivered by the
Company.
(v) The
Indenture has been duly authorized by the Company and (assuming due
authorization, execution and delivery thereof by the Trustee) when
executed and delivered by the Company will constitute a valid and
binding agreement of the Company, enforceable against the Company
in accordance with its terms except to the extent that enforcement
thereof may be limited by bankruptcy, insolvency, reorganization,
moratorium or other laws now or hereafter in effect relating to
creditors’ rights generally and general principles of equity
whether enforcement is sought at law or in equity, and the
Indenture has been qualified under the Trust Indenture
Act.
(w) The
Securities have been duly authorized for issuance and sale pursuant
to the Terms Agreement (or will have been so authorized prior to
each issuance of Securities) and, when issued, authenticated and
delivered pursuant to the provisions of the Terms Agreement and of
the Indenture against payment of the consideration therefor in
accordance with the Terms Agreement, the Securities will be valid
and binding obligations of the Company entitled to the benefits of
the Indenture and will be enforceable against the Company in
accordance with their terms, subject to bankruptcy, insolvency,
fraudulent transfer, reorganization, moratorium and similar laws of
general applicability relating to or affecting creditors’
rights and to general equity principles; and the Securities and the
Indenture conform or will conform at the time of their issuance or
execution, as the case may be, in all material respects to all
statements relating thereto contained in the Prospectus and the
Disclosure Package.
Section 2.
Purchase and Sale. The several commitments of the
Underwriters to purchase, and the obligation of the Company to
sell, Securities pursuant to any Terms Agreement shall be deemed to
have been made on the basis of the representations and warranties
herein contained and shall be subject to the terms and conditions
herein set forth.
Payment
of the purchase price for, and delivery of, any Firm Securities to
be purchased by the Underwriters shall be made at such time and
place and on such date as specified in the applicable Terms
Agreement (unless postponed in accordance with the provisions of
Section 9 hereof) (each such time and date being referred to
herein as a “ Closing Date ”). Payment shall be
made to the Company in Federal or other funds immediately available
in New York City or by such other means as may be specified in the
Terms Agreement against delivery to you for the respective accounts
of the Underwriters of the Firm Securities to be purchased by
them.
9
If
so specified in the applicable Terms Agreement, the Underwriters
shall have a one-time right to purchase, severally and not jointly,
up to the principal amount of Additional Securities set forth in
the applicable Terms Agreement at the purchase price set forth in
the applicable Terms Agreement plus accrued interest, if any.
Additional Securities may be purchased solely for the purpose of
covering over-allotments made in connection with the offering of
the Firm Securities. If any Additional Securities are to be
purchased, each Underwriter agrees, severally and not jointly, to
purchase the principal amount of Additional Securities (subject to
such adjustments to eliminate fractions of $1,000 as you may
determine) that bears the same proportion to the total principal
amount of Additional Securities to be purchased as the principal
amount of Firm Securities set forth opposite its name in the
applicable Terms Agreement bears to the total principal amount of
Firm Securities.
Payment
of the purchase price for, and delivery of, any Additional
Securities to be purchased by the Underwriters shall be made at
such time (which may be the same as the Closing Date but shall in
no event be earlier than the Closing Date nor later than ten
business days after the giving of the notice hereinafter referred
to) and place as shall be designated in a written notice from you
to the Company of your determination, on behalf of the
Underwriters, to purchase the principal amount, specified in such
notice, of Additional Securities, or at such other time, in any
event not later than 30 days after the Closing Date, as shall
be designated in writing by the Underwriters. The time and date of
such payment are hereinafter referred to as the “ Option
Closing Date .” The notice of the determination to
exercise the option to purchase Additional Securities and of the
Option Closing Date may be given at any time within 30 days
after the date of the Terms Agreement.
Certificates
evidencing the Firm Securities and Additional Securities shall be
in definitive, global form and registered in the name of Cede &
Co., as nominee for The Depository Trust Company, unless you shall
request otherwise in writing not less than two full business days
prior to the Closing Date or the Option Closing Date, as the case
may be. The certificates evidencing the Firm Securities and
Additional Securities shall be delivered to you at the Closing Date
or the Option Closing Date, as the case may be, for the respective
accounts of the several Underwriters, with any transfer taxes
payable in connection with the transfer of the Securities to the
Underwriters duly paid, against payment of the purchase price
therefor.
Section 3.
Covenants of the Company. The Company covenants with each of
you, and with each Underwriter participating in the applicable
offering of Securities, as follows with respect to such offering of
Securities:
(a) As soon
as practicable, following the execution of the applicable Terms
Agreement, the Company will prepare the Prospectus setting forth
the principal amount of each series of the Securities covered
thereby and their terms not otherwise specified in the Indenture,
the names of the Underwriters participating in the offering and the
principal amount of each series of the Securities which each
severally has agreed to purchase, the names of the Underwriters
acting as co-managers in connection with the offering, the price at
which each series of the Securities is to be purchased by the
Underwriters from the Company, the initial public offering price of
each such series, if applicable, the selling concession and
reallowance applicable to each such series, if any, any Additional
Securities information and such other information as you and the
Company deem appropriate in connection with the offering of the
Securities. The Company will
10
transmit copies
of the Prospectus to the Commission in compliance with
Rule 424 under the Act and will furnish to the Underwriters
named therein as many copies of the Prospectus and the Disclosure
Package as you shall reasonably request for the purposes
contemplated by the Act or the Rules and Regulations.
(b) If at any
time when the Prospectus (or in lieu thereof the notice referred to
in Rule 173(a) under the Act) is required by the Act to be
delivered in connection with sales of such Securities any event
shall occur or condition exist as a result of which it is necessary
to further amend or supplement the Prospectus in order that the
Prospectus will not include an untrue statement of a material fact
or omit to state any material fact necessary to make the statements
therein not misleading in the light of circumstances existing at
the time it is delivered to a purchaser or if it shall be necessary
at any time to amend or supplement the Registration Statement or
the Prospectus in order to comply with the requirements of the Act
or the Rules and Regulations, the Company will, as soon as
practicable, prepare and file (if required) with the Commission
such amendment or supplement, whether by filing documents pursuant
to the Exchange Act or otherwise, as may be necessary to correct
such untrue statement or omission or to make the Registration
Statement comply with such requirements.
(c) If the
Disclosure Package is being used to solicit offers to buy the
Securities at a time when the Prospectus is not yet available to
prospective purchasers and any event shall occur or condition exist
as a result of which it is necessary to amend or supplement the
Disclosure Package in order to make the statements therein, in the
light of the circumstances under which they were made, not
misleading, or if any event shall occur or condition exist as a
result of which the Disclosure Package conflicts with the
information contained in the Registration Statement then on file,
or if, in the opinion of counsel for the Underwriters, it is
necessary to amend or supplement the Disclosure Package to comply
with applicable law, the Company will prepare, file with the
Commission and furnish, at its own expense, to the Underwriters and
to any dealer upon request, either amendments or supplements to the
Disclosure Package so that the statements in the Disclosure Package
as so amended or supplemented will not contain any statement of
untrue material fact or omit to state a material fact necessary in
order to make the statements not misleading, in the light of the
circumstances when delivered to a prospective purchaser, or so that
the Disclosure Package, as amended or supplemented, will no longer
conflict with the Registration Statement, or so that the Disclosure
Package, as amended or supplemented, will comply with applicable
law.
(d) The
Company will make generally available to its security holders as
soon as practicable, but in any event not later than 18 months
after the date of the Terms Agreement relating to such Securities,
earnings statements of the Company and its subsidiaries (which need
not be audited) complying with Section 11(a) of the Act and the
Rules and Regulations (including, at the option of the Company,
Rule 158 under the Act).
(e) The
Company, during the period when the Prospectus is required by the
Act to be delivered in connection with sales of such Securities,
will, except in the case of reports filed pursuant to the Exchange
Act, give you notice of its intention to file any amendment to the
Registration Statement or any amendment or supplement to the
Prospectus or the Disclosure Package, whether pursuant to the Act
or otherwise and will furnish you with copies of any
such
11
amendment or
supplement or other documents proposed to be filed in a reasonable
time for review by the Underwriters in advance of
filing.
(f) The
Company, during the period when the Prospectus is required by the
Act to be delivered by you in connection with sales of Securities,
will notify each of you, as soon as practicable, and confirm the
notice in writing, of: (i) the effectiveness of any amendment
to the Registration Statement; (ii) the mailing or delivery to
the Commission for filing of any supplement to the Prospectus or
the Disclosure Package, or any document to be filed pursuant to the
Exchange Act; (iii) the receipt of any comments
from
|